About the Journal : Journal of Addiction Medicine

Journal Logo

About the Journal


Published bi-monthly, ASAM’s peer-reviewed Journal promotes excellence in the practice of addiction medicine and in clinical research, supporting addiction medicine as a mainstream medical sub-specialty. The Journal is published for physicians and other health professionals who need the most current news and information related to treatment of addiction disorders. Under the guidance of an esteemed Editorial Board, Journal of Addiction Medicine’s peer-reviewed articles focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics. Each issue of the journal offers CME/MOC opportunities. The Journal is currently ranked in the Substance Abuse category of the Journal Citation Reports' Web Science Citation Index (SCI).  
JAM is read by one of the largest addiction-specialty physician readerships on the globe: ASAM members as well as their professional colleagues. Additionally, JAM was accepted for citation in June 2011 by the National Library of Medicine. This development facilitates increased dissemination of content and has since been augmented with significantly expanded pagination. Since inception, JAM has been cited by peer-reviewed global search engines, including PubMed/NLM, BIOSIS Previews, PsychINFO, Ebsco A-Z, CNKI – The China National Knowledge Infrastructure, ProQuest Summons, Sage Knowledge, SWETS, TDNet, and Journal Guide.​

Topics covered in the journal: 

•addiction and substance use in pregnancy

•adolescent addiction and at-risk use

•the drug-exposed neonate


•all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances


•neuroimaging techniques

•treatment of special populations

•treatment, early intervention and prevention of alcohol and drug use disorders

•methodological issues in addiction research

•pain and addiction, prescription drug use disorder

•co-occurring addiction, medical and psychiatric disorders

•pathological gambling disorder, sexual and other behavioral addictions

•pathophysiology of addiction

•behavioral and pharmacological treatments

•issues in graduate medical education


•health services delivery

•ethical, legal and liability issues in addiction medicine practice

•drug testing

•self- and mutual-help​

Publication & Editorial Staff Contacts

John Henry Scott

Director, Journal Publishing​
Beth Guthy 

Production Editor
Alicia Wallace

Marketing Manager
Lori Hart 

Permission to reuse material in another publication or presentation, please email:

Translation, Rights & Licensing
For Translation approval or License to republish and distribute, please email one of the following:

LWW Business Offices
Two Commerce Square
2001 Market Street
Philadelphia, PA 19103

David A. Fiellin, MD, FASAM

Kelly E. Dunn, PhD

Ismene Petrakis, MD

Frank J. Vocci, PhD​

Acting Co-Editors
Benjamin H. Han, MD, MPH
University of California, San Diego

Marcela Smid MD MA MS
University of Utah

Statistical Editors
Debbie M. Cheng, Sc.D.
Boston University School of Public Health

Sara Lodi, PhD
Boston University School of Public Health​

Charles Maynard, PhD
University of Washington

Antover Tuliao, PhD
Texas Tech University

Managing Editor
Michael A. Arends

Editorial Fellows
Alexa A. Anderson (Lopez), PhD
University of Wisconsin-Milwaukee

Chung Jung Mun ("Moon"), PhD
Arizona State University

Orrin D. Ware PhD, MPH, MSW
University of North Carolina at Chapel Hill School of Social Work

Founding Editors and First Edition
George Koob, PhD

Shannon C. Miller, MD, DFASAM, DFAPA 
Martha Wunsch, MD, DFASAM, FAAP 

Inaugural Edition: April 2007

Editor Biographies


Kelly Dunn, Ph.D. is an Associate Professor in the Behavioral Pharmacology Research Unit in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University. Her research interests include mechanisms underlying opioid use disorder and development of effective treatment strategies, comorbid conditions in persons with opioid use disorder, and opioid overdose. Her research also includes randomized controlled evaluations of medications for alcohol use disorder and tobacco use, as well as development of standardized outcome measures.

Benjamin Han MD, MPH is an internist and board-certified in addiction medicine and geriatric medicine, an Associate Professor in the Division of Geriatrics, Gerontology, and Palliative Care at the University of California San Diego, and a primary care physician at the VA San Diego Healthcare System. His research focuses on psychoactive substance use among older adults and the development of care models that integrate the principles of geriatric medicine, addiction medicine, and harm reduction to improve the health of adults living with substance use disorders and co-occurring chronic medical diseases.

Ismene L. Petrakis, M.D. is an addiction psychiatrist, a Professor of Psychiatry at the Yale University School of Medicine and the Chief of Psychiatry and Mental Health Services at VA Connecticut Healthcare System.  She is also the Director of the Addiction Psychiatry Residency at Yale University School of Medicine and the principal investigator of a National Institute of Drug Abuse (NIDA-T32) training grant. She is certified by the American Board of Psychiatry and Neurology and Addiction Psychiatry.

Marcela Smid MD, MA, MS is a board certified Maternal Fetal Medicine and Addiction Medicine physician at the University of Utah. She is the medical director of the Substance Use & Pregnancy – Recovery, Addiction, Dependence (SUPeRAD) specialty prenatal clinic. She was an NIH K12Women’s Reproductive Health Research (WRHR) Program scholar.  Her research focus is on perinatal addiction, care models for pregnant and postpartum women with substance use disorders, maternal mortality, and maternal mental health.

Frank J. Vocci, PhD, is President and Senior Research Scientist of Friends Research Institute in Baltimore, Maryland. He has previously served as Director of the National Institute on Drug Abuse’s Division of Pharmacotherapies and Medical Consequences of Drug Abuse and is a Fellow and Past-President of The College on Problems of Drug Dependence.  His research interests include developing medications for treating nicotine and stimulant use disorder, developing new treaments for opioid use disorder, and evaluating best practices for treatment of opiate users with criminal justice involvement.